V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626535 | 330006644 | EJU04 | 5800 | X724 | 1 | 2017-07-26 | FLUOROURACIL | 330003017 | 330003395 | 330006645 |
| 16626536 | 330006644 | EKJ | 145 | X724 | 1 | 2017-07-27 | CISPLATIN | 330003017 | 330003395 | 330006645 |
| 16626537 | 330006644 | EJN | 1700 | null | 1 | 2017-07-28 | FLUOROURACIL | 330003017 | 330003395 | 330006645 |
| 16626538 | 330006644 | EPQ | 480 | X721 | 2 | 2017-07-28 | NOT CHEMO | 330003017 | 330003395 | 330006645 |
| 16626539 | 330006646 | EPH | 170 | X729 | 1 | 2017-05-17 | DACTINOMYCIN | 330003028 | 330007807 | 330006647 |
| 16626540 | 330006646 | EGU08 | 820 | X721 | 1 | 2017-05-17 | VINCRISTINE | 330003028 | 330007807 | 330006647 |
| 16626541 | 330006646 | ELW | 150 | null | 1 | 2017-05-17 | STEROID | 330003028 | 330007807 | 330006647 |
| 16626542 | 330006646 | EEI00 | 160 | null | 1 | 2017-05-17 | CISPLATIN | 330003028 | 330007807 | 330006647 |
| 16626543 | 330006649 | EPH | 20 | X721 | 1 | 2015-12-26 | MESNA | 330003049 | 330010251 | 330006650 |
| 16626544 | 330006650 | EEI00 | 150 | null | 1 | 2016-07-04 | GEMCITABINE | 330003051 | 330003404 | 330006651 |
| 16626545 | 330006650 | EEI00 | 155.17 | null | 1 | 2016-07-04 | CYCLOPHOSPHAMIDE | 330003051 | 330003404 | 330006651 |
| 16626546 | 330006650 | EEI00 | 160 | X721 | 1 | 2016-07-04 | ETOPOSIDE | 330003051 | 330003404 | 330006651 |
| 16626547 | 330006650 | EEI00 | 1880 | null | 1 | 2016-07-18 | FLUOROURACIL | 330003051 | 330003404 | 330006651 |
| 16626548 | 330006650 | EKD50 | 606 | null | 1 | 2016-07-18 | NOT CHEMO | 330003051 | 330003404 | 330006651 |
| 16626549 | 330006652 | ECL02 | 55 | null | 1 | 2017-12-09 | OXALIPLATIN | 330003069 | 330003406 | 330006653 |
| 16626550 | 330006652 | EEI00 | 75 | X721 | 1 | 2017-12-10 | VINCRISTINE | 330003069 | 330003406 | 330006653 |
| 16626551 | 330006653 | ECL02 | 1.5 | X724 | 1 | 2015-01-26 | CYCLOPHOSPHAMIDE | 330003076 | 330003407 | 330006654 |
| 16626552 | 330006653 | ELW | 100 | X721 | 1 | 2015-02-09 | DOCETAXEL | 330003076 | 330003407 | 330006654 |
| 16626553 | 330006653 | EK1EN | 8 | X721 | 1 | 2015-02-09 | NOT CHEMO | 330003076 | 330003407 | 330006654 |
| 16626554 | 330006653 | EJR | 2960 | X724 | 1 | 2015-02-16 | AZD9150 | 330003076 | 330003407 | 330006654 |
| 16626555 | 330006656 | ECL02 | 1.5 | null | 1 | 2014-07-09 | TRIAL | 330003086 | 330003410 | 330006657 |
| 16626556 | 330006656 | EEI00 | 80 | X721 | 1 | 2014-07-12 | CYCLOPHOSPHAMIDE | 330003086 | 330003410 | 330006657 |
| 16626557 | 330006656 | EEI00 | 10 | null | 1 | 2014-08-09 | CISPLATIN | 330003086 | 330003410 | 330006657 |
| 16626558 | 330006656 | EZ102 | 1.5 | X724 | 1 | 2014-08-10 | NOT CHEMO | 330003086 | 330003410 | 330006657 |
| 16626559 | 330006656 | EN710 | 40 | null | 2 | 2014-08-10 | MULTIPLE | 330003086 | 330003410 | 330006657 |
| 16626560 | 330006657 | EK1EN | 3.25 | null | 1 | 2015-09-13 | VINCRISTINE | 330003127 | 330012336 | 330006658 |
| 16626561 | 330006657 | EPH | 110 | null | 2 | 2015-09-14 | PACLITAXEL | 330003127 | 330012336 | 330006658 |
| 16626562 | 330006657 | EJRNN | 2640 | X721 | 1 | 2015-09-14 | IFOSFAMIDE | 330003127 | 330012336 | 330006658 |
| 16626563 | 330006657 | EPH | 0.75 | X729 | 1 | 2015-09-14 | RITUXIMAB | 330003127 | 330012336 | 330006658 |
| 16626564 | 330006660 | EK1EN | 10 | X292 | 1 | 2013-07-28 | DOXORUBICIN | 330003157 | 330003413 | 330006661 |
| 16626565 | 330006660 | EJR | 6320 | null | 1 | 2013-07-28 | MESNA | 330003157 | 330003413 | 330006661 |
| 16626566 | 330006660 | EJR | 0.75 | X721 | 1 | 2013-07-28 | IFOSFAMIDE | 330003157 | 330003413 | 330006661 |
| 16626567 | 330006661 | EK1EN | 125 | null | 1 | 2014-09-26 | DOXORUBICIN | 330003160 | 330003415 | 330006662 |
| 16626568 | 330006661 | EEI00 | 50 | X721 | 1 | 2014-09-26 | IFOSFAMIDE | 330003160 | 330003415 | 330006662 |
| 16626569 | 330006661 | EOI | 0.75 | X724 | 1 | 2014-09-26 | IFOSFAMIDE | 330003160 | 330003415 | 330006662 |
| 16626570 | 330006661 | ECL01 | 2640 | null | 1 | 2014-09-26 | ETOPOSIDE | 330003160 | 330003415 | 330006662 |
| 16626571 | 330006661 | EEI00 | 65 | X724 | 1 | 2014-09-26 | IRINOTECAN | 330003160 | 330003415 | 330006662 |
| 16626572 | 330006661 | EEI00 | 4450 | X721 | 1 | 2014-09-27 | DOXORUBICIN | 330003160 | 330003415 | 330006662 |
| 16626573 | 330006661 | EII | 100 | null | 1 | 2014-09-28 | DOCETAXEL | 330003160 | 330003415 | 330006662 |
| 16626574 | 330006663 | EPH | 27 | null | 1 | 2015-03-08 | DOXORUBICIN | 330003163 | 330003416 | 330006664 |
| 16626575 | 330006664 | ERA20 | 200 | X721 | 1 | 2016-02-19 | TOPOTECAN | 330003163 | 330003416 | 330006665 |
| 16626576 | 330006664 | E1UZ0 | 10 | X729 | 1 | 2016-02-19 | DAUNORUBICIN | 330003163 | 330003416 | 330006665 |
| 16626577 | 330006664 | E0N03 | 55 | X292 | 2 | 2016-02-19 | IFOSFAMIDE | 330003163 | 330003416 | 330006665 |
| 16626578 | 330006664 | ECL02 | 2750 | X724 | 1 | 2016-02-22 | TRIAL | 330003163 | 330003416 | 330006665 |
| 16626579 | 330006665 | ECL01 | 1.7 | X721 | 1 | 2016-07-07 | ETOPOSIDE | 330003174 | 330003417 | 330006666 |
| 16626580 | 330006666 | EC4 | 1900 | X721 | 1 | 2018-03-31 | CYTARABINE | 330003181 | 330003418 | 330006667 |
| 16626581 | 330006666 | EEI00 | 190 | X721 | 1 | 2018-03-31 | MESNA | 330003181 | 330003418 | 330006667 |
| 16626582 | 330006666 | EUZ | 1.1 | null | 1 | 2018-04-07 | CISPLATIN | 330003181 | 330003418 | 330006667 |
| 16626583 | 330006666 | EOI | 1 | X729 | 1 | 2018-04-14 | MULTIPLE | 330003181 | 330003418 | 330006667 |
| 16626584 | 330006666 | EXO | 0.95 | null | 1 | 2018-04-14 | CARBOPLATIN | 330003181 | 330003418 | 330006667 |